XML 13 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Class A Common Stock
Class V Common Stock
Members' Equity
Common Stock
Class A Common Stock
Common Stock
Class V Common Stock
Retained Earnings / (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Total Stockholders' Equity (Deficit) Attributable to biote Corp.
Non Controlling Interest
Beginning balance, units at Dec. 31, 2020       982,800            
Beginning balance at Dec. 31, 2020 $ (17,075)           $ (17,052) $ (23) $ (17,075)  
Distributions (11,402)           (11,402)   (11,402)  
Net income (loss) 32,619           32,619   32,619  
Other comprehensive income (loss) (17)             (17) (17)  
Ending balance, units at Dec. 31, 2021       982,800            
Ending balance at Dec. 31, 2021 4,125           4,165 (40) 4,125  
Net income (loss) 9,143           9,143   9,143  
Other comprehensive income (loss) 1             1 1  
Beginning balance, units at Dec. 31, 2021       982,800            
Beginning balance at Dec. 31, 2021 4,125           4,165 (40) 4,125  
Distributions (12,886)           (9,575)   (9,575) $ (3,311)
Net income (loss) 1,324                  
Business Combination: Capitalized transaction costs (12,282)           (12,282)   (12,282)  
Share-based compensation 82,180           82,180   82,180  
Settlement of phantom equity rights (7,250)           (7,250)   (7,250)  
Vesting of RSUs (424)           (424)   (424)  
Vesting of RSUs, shares         1,950,557          
Issuance of shares under SEPA 561           561   561  
Issuance of shares under SEPA, shares     48,565,824   130,559          
Ending balance at Dec. 31, 2022 (58,274)       $ 1 $ 5 (44,460) (5) (44,459) (13,815)
Ending balance, shares at Dec. 31, 2022         9,655,387 48,565,824        
Business Combination: Reverse recapitalization on May 26, 2022, units       (982,800)            
Business Combination: Reverse recapitalization on May 26, 2022 (113,622) $ 1 $ 5       (113,628)   (113,622)  
Business Combination: Reverse recapitalization on May 26, 2022, shares   7,574,271 48,565,824              
Business Combination: Noncontrolling interest on May 26, 2022             3,619 34 3,653 (3,653)
Net income (loss) (7,819)           (969)   (969) (6,850)
Other comprehensive income (loss) 1                 (1)
Ending balance at Dec. 31, 2022 $ (58,274)       $ 1 $ 5 $ (44,460) $ (5) $ (44,459) $ (13,815)
Ending balance, shares at Dec. 31, 2022         9,655,387 48,565,824